Phenmetrazine

This classification denotes a cns stimulant and anorexiant with the molecular formula C11H15NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) XA501VL3VR, chemically known as 3-methyl-2-phenyltetrahydro-2h-1,4-oxazine but more generally known as phenmetrazine, which bears US NIH Compound Identifier 4762. European Medicines Agency schedules Phenmetrazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09769MIG. The term PHENMETRAZINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). PHENMETRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule phenmetrazine under HS 29349100 and SITC 51579. As of Q4 2014, PHENMETRAZINE remains US FDA's Preferred Term for this commodity. Phenmetrazine bears US NLM identifiers UMLS ID C0031411 and NCI Concept Code C66372. SMILES: CC1C(OCCN1)C2=CC=CC=C2.